News
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023]
The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in the fifth edition of Banco Sabadell’s BStartup Health program, which received applications from 127 start-ups.
Related News
Josep Samitier joins Fraunhofer Spain Research as Director [19-01-2026]
Nanobiotechnology, Nanomedicine, Scientific Policy
Nanoparticle therapy reprograms tumor immune cells to attack cancer from within [02-01-2026]
Nanobiotechnology, Nanomedicine
Nanozigzags, a new biomaterial, can enhance cancer immunotherapy efficacy by nearly 70% [30-12-2025]
Nanobiotechnology, Nanomedicine
Josep Samitier concludes thirteen years at the helm of IBEC [17-12-2025]
Nanobiotechnology, Scientific Policy
Quantum Computing Helps Design New Cancer Drug Candidates [23-01-2025]
Nanomedicine, Quantum Science
CLOSE
Sitemap
  NEWS
  CONFERENCES
  JOBS
  PH REPORTS

ยฉ Phantoms Foundation 2026